It is a pharma private limited company based in Changodar, Gujarat, India, established in 1999.
1999 | Changodar, Gujarat, India | ActiveLypho-Med Remedies Private Limited, a active private limited company, was established on 13 July 1999 in Changodar, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24231GJ1999PTC036282. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.70 M.
It upholds a compliant status. Its leadership includes Kaushik Vithaldas Patel (Director), Vijaykumar Himatlal Lavri (Director), Haresh Valjibhai Radadiya (Director). It holds no open charges and ₹2.51 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shed No.4,5,6 & 7, Silvar Infra Hub B/H Sakar Pharma, Ahmedabad-Bavla Road,, Ta.Sanand, Changodar, Gujarat, 382213.
U24231GJ1999PTC036282
036282
13 July 1999
₹3.00 M
₹2.70 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Lypho-Med Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kaushik Vithaldas Patel | Director | 13 Jul 1999 | Current |
| Vijaykumar Himatlal Lavri | Director | 13 Jul 1999 | Current |
| Haresh Valjibhai Radadiya | Director | 13 Jul 1999 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lypho-Med Remedies Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.89% increase. The company also saw a substantial improvement in profitability, with a 165.26% increase in profit. The company's net worth moved up by a moderate rise of 4.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Lypho-Med Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹25,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2009 | Bank Of India | ₹0.50 M | Satisfied |
| 23 Jan 2009 | Bank Of India | ₹5.00 M | Satisfied |
| 19 Sep 2006 | Bank Of India | ₹4.50 M | Satisfied |
| 15 Sep 2006 | Bank Of India | ₹4.50 M | Satisfied |
| 17 Jun 2000 | Bank Of India | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lypho-Med Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lypho-Med Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lypho-Med Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lypho-Med Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Lypho-Med Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Progress on A charge registered on 23 Jan 2009 via Charge ID 10140508 with Bank Of India was fully satisfied on 20 Apr 2018. was documented.
Progress on A charge registered on 23 Jan 2009 via Charge ID 10140510 with Bank Of India was fully satisfied on 10 Oct 2017. was documented.
A charge with Bank Of India of Rs. 0.50 M registered on 23 Jan 2009 with Charge ID 10140508 was modified on 19 Sep 2017. was recorded as a recent event.
A charge with Bank Of India amounted to Rs. 5.00 M with Charge ID 10140510 was registered on 23 Jan 2009. was recorded as a recent event.
The CIN of Lypho-Med Remedies Private Limited is U24231GJ1999PTC036282.
Lypho-Med Remedies Private Limited is headquartered at Shed No.4,5,6 & 7, Silvar Infra Hub B/H Sakar Pharma, Ahmedabad-Bavla Road,, Ta.Sanand, Changodar, Gujarat, 382213.
Lypho-Med Remedies Private Limited was incorporated on 13 July 1999.
The current directors of Lypho-Med Remedies Private Limited are
The primary industry of Lypho-Med Remedies Private Limited is Pharma.
Lypho-Med Remedies Private Limited is unlisted.
The authorized capital of Lypho-Med Remedies Private Limited is ₹3.00 M, and the paid-up capital is ₹2.70 M.
The compliance status of Lypho-Med Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX